CFO
ABBV icon

Custos Family Office’s AbbVie ABBV Stock Holding History

Custos Family Office’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$322K Buy
1,279
+41
+3% +$8.82K 0.19% 56
2026
Q1 		$269K Sell
1,238
-40
-3% -$8.87K 0.19% 56
2025
Q4 		$292K Sell
1,278
-212
-14% -$48.3K 0.2% 52
2025
Q3 		$345K Buy
1,490
+112
+8% +$22.8K 0.2% 49
2025
Q2 		$256K Buy
1,378
+236
+21% +$43.9K 0.08% 65
2025
Q1 		$239K Buy
+1,142
New +$222K 0.08% 60

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Custos Family Office's ABBV Position: Q2 2026 in Review

Custos Family Office increased its AbbVie (ABBV) stake by 3.3% in Q2 2026, buying an estimated $8.82K and bringing the position to 1,279 shares worth $322K. The position accounts for 0.19% of the portfolio, ranked #56.

Custos Family Office first reported a position in ABBV in Q1 2025 and has held it in 6 quarters since. The position peaked at $345K in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Custos Family Office held 1,279 shares of AbbVie worth $322K as of Q2 2026.
  • Custos Family Office bought 41 AbbVie shares in Q2 2026, an estimated $8.82K.
  • AbbVie made up 0.19% of Custos Family Office's portfolio in Q2 2026, its #56 holding.
  • Custos Family Office first reported a position in AbbVie in Q1 2025 and has held it in 6 quarters since.
  • Custos Family Office's AbbVie position peaked at $345K in Q3 2025.
  • 4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Custos Family Office's 13F filing for Q2 2026, filed 19 Aug 2026.